Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 2 2Phase 3 1

Status

Terminated 2Recruiting 2Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Pain 1Neuralgia 1Lymphoma 1Earache 1Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Pregabalin × Clear all
NCT02924675 2019-10-14

LYRORL

University Hospital, Lille

Phase 2 Terminated
42 enrolled

Earache, Neuralgia

NCT03407430 2018-06-26

Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
11 enrolled 17 charts
BreastLymphoid

Breast Neoplasms, Lymphoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡